Last reviewed · How we verify
MSB-CAR001 Combined With Hyaluronan
At a glance
| Generic name | MSB-CAR001 Combined With Hyaluronan |
|---|---|
| Also known as | Anterior Cruciate Ligament Reconstruction, Adult Stem Cells, Knee Injection |
| Sponsor | Mesoblast, Ltd. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy Study of MSB-CAR001 in Subjects 6 Weeks Post an Anterior Cruciate Ligament Reconstruction (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- MSB-CAR001 Combined With Hyaluronan CI brief — competitive landscape report
- MSB-CAR001 Combined With Hyaluronan updates RSS · CI watch RSS
- Mesoblast, Ltd. portfolio CI